ConvergePartners Co., Ltd. is pleased to announce that it has entered into a business alliance with NNG Co., Ltd. to jointly develop the "Synapse" series of clinical AI platforms for…
Guardant Health, Inc., a leading precision oncology company, and ConcertAI, a leading…
CAC Corporation, a company working to bring about digital innovation in society…
FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery…
NEC Corporation (hereinafter referred to as NEC) and biomy, Inc. (hereinafter referred…
Primo Biotechnology ("Primo") has announced a strategic collaboration with SHINE Technologies ("Shine"),…
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that…
Daiichi Sankyo Company, Ltd announced that it will pay Glycotope $132.5 million…
Guardant Health, Inc., a leading precision oncology company, and ConcertAI, a leading…
CAC Corporation, a company working to bring about digital innovation in society…
FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery…
NEC Corporation (hereinafter referred to as NEC) and biomy, Inc. (hereinafter referred…
Primo Biotechnology ("Primo") has announced a strategic collaboration with SHINE Technologies ("Shine"),…
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that…
Daiichi Sankyo Company, Ltd announced that it will pay Glycotope $132.5 million…
Sign in to your account